powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1912229121
Silvia Cuadra Mongalo
Endocrinology
Port Orange,
FL
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
3,701
Beneficiaries
—
Total drug cost
$975K
Distinct drugs
37
Brand share
58.3%
Top prescribed drugs
Dapagliflozin Propanediol
543 claims
Rosuvastatin Calcium
254 claims
Levothyroxine Sodium
250 claims
Pioglitazone Hcl
186 claims
Exenatide Microspheres
162 claims
